The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Skeletal-related events (SREs), baseline comorbidity, and survival among elderly patients (pts) with metastatic (M1) prostate cancer (PCa) in SEER-Medicare.
Ebere Onukwugha
Consultant or Advisory Role - Janssen
Research Funding - Bayer; Pfizer
Candice Yong
No relevant relationships to disclose
C. Daniel Mullins
Consultant or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Novartis; Pfizer
Honoraria - Bayer; Celgene; Pfizer
Research Funding - Amgen; Bayer; Pfizer
Brian S. Seal
Employment or Leadership Position - Bayer
Stock Ownership - Bayer
Arif Hussain
Research Funding - Amgen; Bayer